hotspot -WSS

hotspot

author：comprehensive 2025-09-30 15:17:11 - browse：1568

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Stoke drug shows lower activity against childhood epilepsy

WSS

STAT Report: Patient voices and perspectives

The mammogram wars are not over

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

Trump allegedly attempted to have surveillance video deleted: Special Counsel

The battle over 'scope creep' and who gets to be called 'doctor'

The battle over 'scope creep' and who gets to be called 'doctor'

explore

hotspot

Wikipedia

Bright Health sells Medicare Advantage business to Molina

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

VC firm RA Capital starts a new synthetic biology incubator

United colonoscopy coverage change 'may cost lives,' doctors say

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Jerome Adams on the need for new antivirals for Covid

Ford recalls 870K F

Medicare details structure of new drug price negotiation program

What causes rare myocarditis in young men after Covid vaccines?

entertainment

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

The mammogram wars are not over

STAT Report: Patient voices and perspectives

'The boss' wants server deleted: New allegations emerge in Trump indictment

The haunting brain science of long Covid

Search called off for baby washed away in Pennsylvania flash flood

focus

knowledge

Wikipedia

Wikipedia